Business · 1 sources covering this

Dr Lal PathLabs expands advanced diagnostics portfolio with genomics buy

The ₹168 crore acquisition of a 70 per cent stake in SN Genelab is expected to strengthen Dr Lal's genomics expertise and broaden its advanced diagnostics portfolio

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Dr Lal PathLabs expands advanced diagnostics portfolio with genomics buy
The ₹168 crore acquisition of a 70 per cent stake in SN Genelab is expected to strengthen Dr Lal's genomics expertise and broaden its advanced diagnostics portfolio
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/e805299f40cda61183b4e5ef28729328beba10b6"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Dr Lal PathLabs expands advanced diagnostics portfolio with genomics buy"></iframe>

Dr Lal PathLabs expands advanced diagnostics portfolio with genomics buy

How 1 sources are covering this

Dr Lal PathLabs expands advanced diagnostics portfolio with genomics buy

More from Business

Govt Cuts FY27 Market Borrowing Target, Eyes Raising Rs 7.86 Lakh Crore In Second Half

No commitment given to bank unions on five-day work week by Finance Ministry: report

Asian Games: Gulveer Singh Clinches Silver In Men’s 10,000m

Tesla Expands South India Presence With New Experience, Collision Centres In Chennai

Reader

Trust & legal

Across the network